Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Inflammatory Bowel Diseases 2Crohn Disease 2Colitis, Ulcerative 2Lymphoma 1Kidney Transplantation 1Hematologic Neoplasms 1Granulomatous Disease, Chronic 1Graft vs Host Disease 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Bronchiolitis Obliterans Syndrome 1Bipolar Disorder 1

Interventions

etrolizumab 5Infliximab 2Adalimumab 2golimumab 1Papillomavirus Vaccines 1Mesalamine 1Injections 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Andrographis paniculata extract 1ABX464 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Colitis, Ulcerative × Infliximab × Clear all
NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed
397 enrolled 32 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡